Fresenius SE & Co KGaA (OTC Pink - Current Information:FSNUF)
| 32.00 Delayed Data As of Sep 01 |  0.00 / 0.00%Today’s Change | 19.50 Today|||52-Week Range 32.43 | +18.80% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $18.0B |
Company Description
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Contact Information
Fresenius SE & Co. KGaA Else-Kröner-Strasse 1 Bad Homburg Hessen 61352 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Michael Sen | Chief Executive Officer |
| Sara Hennicken | Chief Financial Officer |
| Rice Powell | Chief Executive Officer-Fresenius Medical Care |
| Francesco de Meo | Chief Executive Officer-Fresenius Helios |
| Pierluigi Antonelli | Chief Executive Officer-Fresenius Kabi |
